Investor FAQs

Anterix's public offering was made on February 3, 2015.

Anterix's common stock is listed on NASDAQ Capital Market under the symbol ATEX.

Anterix currently does not have a direct purchase program. Anterix's common stock can be purchased through a registered broker or a financial institution that deals in securities.

No, Anterix's common stock does not pay a dividend.

Continental Stock Transfer & Trust Company is Anterix's stock transfer agent.

Please contact the registered broker from whom you purchased Anterix's common stock.

Anterix's fiscal years runs from April 1st to March 31st

Grant Thornton is Anterix's independent auditor.

Please visit our SEC Filings section on the website to view and download all of Anterix's financial statements. If you require a hard copy, please Contact Us.

Please visit our SEC Filings section on the website to view and download all of Anterix's financial statements. If you require a hard copy, please Contact Us.

Please visit our Board of Directors section on the website to learn about Anterix's board of directors.

Please visit our Committee Composition section on the website to learn about Anterix's board committee members.

For questions related to Anterix and Anterix stock contact: 
Natasha Vecchiarelli
Director, Investor Relations and Corporate Communications
Email: nvecchiarelli@anterix.com
Phone: 973-531-4397

Please contact the registered broker from whom you purchased Anterix's common stock.

The date for the next annual meeting of shareholders has not been determined; as a shareholder you will receive a formal notification.

For company news, please subscribe to our emails by clicking on the Contact link on the website.

Please visit our SEC Filings section to view and download all of Anterix's financial statements. Or if you prefer, please Contact Us. to have electronic hard copies emailed to you.